StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG – Free Report) in a research note released on Monday morning. The brokerage issued a sell rating on the stock. ATA Creativity Global Price Performance Shares of NASDAQ AACG opened at $1.08 on Monday. The business’s 50 day moving average price is $1.15 and its […]
POINT Biopharma Global (NASDAQ:PNT – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Piper Sandler in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $12.50 price objective on the stock. Piper Sandler’s target price suggests a potential downside of 2.19% from the […]
StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG – Free Report) in a research note published on Sunday. The firm issued a sell rating on the stock. ATA Creativity Global Price Performance Shares of NASDAQ AACG opened at $1.08 on Friday. The stock has a market capitalization of $34.72 million, a price-to-earnings ratio […]
Moody Aldrich Partners LLC bought a new stake in POINT Biopharma Global Inc. (NASDAQ:PNT – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 145,442 shares of the company’s stock, valued at approximately $1,318,000. A number of other hedge […]
StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the stock. ATA Creativity Global Price Performance Shares of AACG stock opened at $1.10 on Friday. The company has a debt-to-equity ratio of 0.15, a quick […]